Search for: "UCB GMBH" Results 1 - 12 of 12
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
21 Jan 2019, 9:20 pm by Patent Docs
UCB Pharma GmbH, and once again reviewed whether a failed petitioner in an inter partes review (IPR) proceeding had standing to appeal an adverse judgment. [read post]
14 Jul 2013, 9:23 pm by Patent Docs
Teva Pharmaceuticals USA Inc. et al. 1:13-cv-01148; filed June 28, 2013 in the District Court of Delaware • Plaintiffs: UCB Inc.; UCB Pharma GmbH; Research Corporation Technologies Inc.; Harris FRC Corp. [read post]
7 Sep 2014, 8:35 pm by Patent Docs
(NV) et al. 1:14-cv-01083; filed August 21, 2014 in the District Court of Delaware • Plaintiffs: UCB Inc.; UCB Manufacturing Ireland Ltd.; UCB Pharma GmbH; LTS Lohmann Therapie-Systeme AG • Defendants: Watson Laboratories Inc. [read post]
15 Dec 2013, 8:24 pm by Patent Docs
.; UCB Pharma GmbH • Defendants: Hetero USA Inc.; Hetero Labs Ltd. [read post]
4 Aug 2013, 9:53 pm by Patent Docs
Sun Pharma Global FZE et al. 1:13-cv-05514; filed August 1, 2013 in the Northern District of Illinois • Plaintiffs: UCB, Inc.; UCB Pharma GmbH; Research Corporation Technologies, Inc.; Harris FRC Corp. [read post]
6 Sep 2016, 9:35 pm by Patent Docs
UCB Pharma GmbH PTAB Petition: IPR2016-01665; filed August 22, 2016 Patent at Issue: U.S. [read post]
Patent No. 10,130,589 (the ‘589 patent), assigned to UCB Pharma GmbH and LTH Lohman Therapie-Systeme AG (collectively, “UCB”). [read post]
30 May 2008, 9:09 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
2 Aug 2008, 12:54 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
18 Apr 2008, 2:00 am
Lélos Kai Sia EE (and Others) v GlaxoSmithKline AEVE: (IPKat), US: Bio commends Sen Specter for patent reform stance: (Patent Docs), US: USPTO rules on two of four neural stem cell patents in dispute between StemCells Inc and Neuralstem Inc; parties disagree on how extensively claims amended: (IP Law360), (IPBiz), US: Insmed continues fight for generic biologic approval: (GenericsWeb), Pharma & Biotech - Products Cipralex (Escitalopram) – Lundbeck wins… [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]